| Madhusudhan Reddy, | |
|
3321 Platt Springs Rd, West Columbia, SC 29170-2203 | |
| (803) 708-1226 | |
| (803) 708-1229 |
| Full Name | Madhusudhan Reddy |
|---|---|
| Gender | Male |
| Speciality | Pharmacy Technician |
| Location | 3321 Platt Springs Rd, West Columbia, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124422050 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 15351 (South Carolina) | Secondary |
| 183700000X | Pharmacy Technician | 39364 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Madhusudhan Reddy, 3311 Platt Springs Rd, West Columbia, SC 29170-2203 Ph: (803) 708-1226 | Madhusudhan Reddy, 3321 Platt Springs Rd, West Columbia, SC 29170-2203 Ph: (803) 708-1226 |
News Archive
The University of Alabama at Birmingham and Southern Research have discovered a new drug candidate that offers a major advance in the treatment for diabetes.
An analysis by the New York Health Benefits Exchange projects that in New York, unlike in many other states, the health law will likely lead to lower health premiums next year.
A study by a joint research team including professor Kazuyo Tsuzuki of Toyohashi University of Technology, Department of Architecture and Civil Engineering, National Institute of Advanced Industrial Science and Technology and Asahi Kasei Homes revealed that airflow from an air conditioner stimulates the human body while sleeping and impacts on sleep conditions even if the mean airflow velocity is lower than an insensible level.
Intravenous immune globulin (IVIG) — a common treatment for multisystem inflammatory syndrome in children (MIS-C) — likely works by depleting immune cells called neutrophils, according to a recent study funded by the National Institutes of Health.
DePuy Synthes Companies of Johnson & Johnson, in collaboration with LifeNet Health, today announced the introduction of ViviGen Cellular Bone Matrix, a differentiated cellular allograft for the repair or reconstruction of musculoskeletal defects.
› Verified 7 days ago